Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Christine, Tunon de Lara"'
Autor:
Gilles Houvenaeghel, Alexandre deNonneville, Nicolas Chopin, Jean‐Marc Classe, Chafika Mazouni, Marie‐Pierre Chauvet, Fabien Reyal, Christine Tunon de Lara, Eva Jouve, Roman Rouzier, Emile Daraï, Pierre Gimbergues, Charles Coutant, Anne Sophie Azuar, Richard Villet, Patrice Crochet, Sandrine Rua, Marie Bannier, Monique Cohen, Jean‐Marie Boher
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4023-4032 (2023)
Abstract Background Results of IBCSG‐23‐01‐trial which included breast cancer patients with involved sentinel nodes (SN) by isolated‐tumor‐cells or micro‐metastases supported the non‐inferiority of completion axillary‐lymph‐node‐d
Externí odkaz:
https://doaj.org/article/39181ef7831c4f908a4d040b53e4defe
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, Philippe Gabelle, Julia Pernaut, Francesco Del Piano, Gauthier D’Halluin, Stéphane Lantheaume, Emile Darai, Bassoodéo Beedassy, Caroline Dhainaut-Speyer, Xavier Martin, Sophie Girard, Richard Villet, Emilie Monrigal, Théophile Hoyek, Jean-François Le Brun, Pierre-Emmanuel Colombo, Agnès Tallet, Jean-Marie Boher, SERC trial group
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Based on results of clinical trials, completion ALND (cALND) is frequently not performed for patients with breast conservation therapy and one or two involved sentinel nodes (SN) by micro- or macro-metastases. However, there were limitations
Externí odkaz:
https://doaj.org/article/c13f72211bf3423f91ce4844474dd13c
Autor:
Gilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, Chafika Mazouni, Sylvia Giard, Monique Cohen, Christelle Faure, Hélène Charitansky, Roman Rouzier, Emile Daraï, Delphine Hudry, Pierre Azuar, Richard Villet, Pierre Gimbergues, Christine Tunon de Lara, Marc Martino, Jean Fraisse, François Dravet, Marie Pierre Chauvet, Jean Marie Boher
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background A strong correlation between breast cancer (BC) molecular subtypes and axillary status has been shown. It would be useful to predict the probability of lymph node (LN) positivity. Objective: To develop the performance of multivari
Externí odkaz:
https://doaj.org/article/cf5fdd3c49af48848f87f186d0805d5c
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Christine Tunon de Lara, Pierre Gimbergues, Tristan Gauthier, Christelle Faure-Virelizier, Véronique Vaini-Cowen, Stéphane Lantheaume, Claudia Regis, Emile Darai, Vivien Ceccato, Gauthier D’Halluin, Francesco Del Piano, Richard Villet, Eva Jouve, Bassoodéo Beedassy, Pierrick Theret, Philippe Gabelle, Cécile Zinzindohoue, Pierre Opinel, Catherine Marsollier-Ferrer, Caroline Dhainaut-Speyer, Pierre-Emmanuel Colombo, Eric Lambaudie, Agnès Tallet, Jean-Marie Boher, Others investigators (SERC trial group)
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Three randomized trials have concluded at non inferiority of omission of complementary axillary lymph node dissection (cALND) for patients with involved sentinel node (SN). However, we can outline strong limitations of these trial
Externí odkaz:
https://doaj.org/article/5feb8aa57f254ca5931669b6a71b124c
Autor:
Gilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, Jean-Marc Classe, Fabien Reyal, Chafika Mazouni, Christelle Faure, Alejandra Martinez, Marie-Pierre Chauvet, Emile Daraï, Charles Coutant, Pierre-Emmanuel Colombo, Pierre Gimbergues, Anne-Sophie Azuar, Roman Rouzier, Christine Tunon de Lara, Patrice Crochet, Sandrine Rua, Anthony Gonçalves
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2022, 176, pp.58-69. ⟨10.1016/j.ejca.2022.08.027⟩
European Journal of Cancer, 2022, 176, pp.58-69. ⟨10.1016/j.ejca.2022.08.027⟩
Introduction: Few data have been reported regarding endocrine therapy (ET) in patients with small pT1a-b ER-postive breast cancer (BC). Thus, we conducted a study to detect possible survival improvements due to ET in such patients. Methods: Our retro
Autor:
Jean Palussière, Sophie Auriol, Cécile Mertens, Xavier Buy, Marc Debled, Christine Tunon de Lara
Publikováno v:
Imagerie de la Femme. 33:75-76
Autor:
Nicolas Sevenet, Christine Tunon de Lara, Jeanne Leroux, Françoise Bonnet, Marc Debled, Delfine Lafon, Emmanuelle Barouk-Simonet, Marion Fournier, Adeline Petit, Virginie Bubien, Nathalie Quenel-Tueux, Véronique Brouste, Gaëtan MacGrogan
Publikováno v:
Cancer Research. 82:P2-07
Introduction: Neoadjuvant chemotherapy (NAC) is proposed for locally advanced breast cancer (LABC) to increase the breast conservative treatment (BCT). In France, mastectomy is the risk-reducing prophylactic surgical strategy only for pre-symptomatic
Autor:
Aurélien Rousvoal, Foucauld Chamming's, Anne Jaffre, Véronique Brouste, Manon Mangiardi-Veltin, Claire Senechal, Stéphanie Hoppe, Christine Tunon de Lara
Publikováno v:
Bulletin du Cancer. 108:999-1009
Resume Introduction Chez les femmes considerees a haut risque de cancer du sein, la mastectomie est une alternative a la surveillance rapprochee. La chirurgie mammaire de reduction du risque (CMRR) presente des benefices et des risques, dont l’eval
Autor:
Stephanie Recco, Christine Tunon de Lara, Erik Dumont, Robb Merrill, Emilee Minalga, Jean Palussière, Dennis L. Parker, J. Rock Hadley, Henrik Odéen, Allison Payne, Sara L. Johnson, Lorne W. Hofstetter, Sophie Auriol
Publikováno v:
IEEE Trans Biomed Eng
Objective: This paper presents and evaluates a breast-specific magnetic resonance guided focused ultrasound (MRgFUS) system. A first-in-human evaluation demonstrates the novel hardware, a sophisticated tumor targeting algorithm and a volumetric magne
Autor:
Chafica Mazouni, Youla Kirova, Daniele Fric, Marie-Pierre Chauvet, Marion Richard-Molard, Caroline Cuvier, Bruno Cutuli, Christine Tunon de Lara, Brigitte de Lafontan, Alice Mege, Agnes Carre, Claire Lemanski
Publikováno v:
Clinical Breast Cancer. 20:e164-e172
Background Ductal carcinoma in situ (DCIS) represents 15% of all breast cancers in France. The first national survey was conducted in 2003. The present multi-center real-life practice survey aimed at assessing possible changes in demographic, clinica